Respiratorius AB (XSAT:RESP) E10: kr-4.31 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:RESP Respiratorius AB XSAT:RESP
32 GF Score
Price kr2.42
View Full Analysis

What is Respiratorius AB E10?

Respiratorius AB XSAT:RESP +6.14% 32 E10 is kr-4.31 as of Jun. 2026. GuruFocus rates XSAT:RESP with a GF Score™ of 32/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Respiratorius AB's adjusted earnings per share data for the three months ended in Jun. 2026 was kr-0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-4.31 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-28), Respiratorius AB's current stock price is kr2.42. Respiratorius AB's E10 for the quarter that ended in Jun. 2026 was kr-4.31. Respiratorius AB's Shiller PE Ratio of today is .


Respiratorius AB  (XSAT:RESP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Respiratorius AB E10 Related Terms


Respiratorius AB E10 Historical Data

* Premium members only.

The historical data trend for Respiratorius AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB E10 Chart

Respiratorius AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -5.13 -4.89 -4.51

Respiratorius AB Quarterly Data
Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.73 -4.61 -4.51 -4.38 -4.31

XSAT:RESP vs VRTX, REGN, RVMD: E10 Comparison

For the Biotechnology subindustry, Respiratorius AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Shiller PE Ratio falls into.


XSAT:RESP
32GF Score
Respiratorius AB XSAT:RESP
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Respiratorius AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Respiratorius AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.23/134.6100*134.6100
=-0.230

Current CPI (Jun. 2026) = 134.6100.

Respiratorius AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.810 101.019 -1.079
201609 -2.674 101.138 -3.559
201612 -0.836 102.022 -1.103
201703 -0.905 102.022 -1.194
201706 -1.809 102.752 -2.370
201709 -2.714 103.279 -3.537
201712 -0.825 103.793 -1.070
201803 -0.905 103.962 -1.172
201806 -0.905 104.875 -1.162
201809 -0.905 105.679 -1.153
201812 -0.705 105.912 -0.896
201903 -0.905 105.886 -1.150
201906 -0.922 106.742 -1.163
201909 -0.922 107.214 -1.158
201912 -0.496 107.766 -0.620
202003 -0.922 106.563 -1.165
202006 -0.922 107.498 -1.155
202009 -0.795 107.635 -0.994
202012 -0.921 108.296 -1.145
202103 -0.922 108.360 -1.145
202106 -0.922 108.928 -1.139
202109 -1.000 110.338 -1.220
202112 -1.170 112.486 -1.400
202204 0.000 115.534 0.000
202209 -2.000 122.296 -2.201
202212 0.000 126.365 0.000
202303 -1.000 127.042 -1.060
202306 -1.000 129.407 -1.040
202309 -0.400 130.224 -0.413
202312 -0.840 131.912 -0.857
202403 -0.600 132.205 -0.611
202406 -0.620 132.716 -0.629
202409 -0.420 132.304 -0.427
202412 -0.370 132.987 -0.375
202503 -0.390 132.825 -0.395
202506 -0.350 133.699 -0.352
202509 -0.180 133.480 -0.182
202512 -0.210 133.390 -0.212
202603 -0.210 133.560 -0.212
202606 -0.230 134.610 -0.230

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-4.31 mean?
Respiratorius AB (XSAT:RESP) has a E10 of kr-4.31 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Respiratorius AB and its competitors.
Is Respiratorius AB's E10 too high?
Respiratorius AB's current E10 is kr-4.31. Overall, Respiratorius AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Respiratorius AB's E10 compare to VRTX and REGN?
Respiratorius AB's E10 of kr-4.31 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Respiratorius AB and its competitors. Respiratorius AB's current E10 is kr-4.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Respiratorius AB stock overvalued right now?
Respiratorius AB (XSAT:RESP) has a current E10 of kr-4.31. The current E10 is kr-4.31. Respiratorius AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Respiratorius AB (XSAT:RESP), the current E10 is kr-4.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Respiratorius AB Business Description

Address Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.
32GF Score

Get the complete analysis for XSAT:RESP

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.42
Price